Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03984110 · ClinicalTrials.gov registry record · Phase 4
One Year Trial Evaluating Safety of Ozurdex With Eylea
A Phase 4 study, sponsored by Texas Retina Associates.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT03984110 is a Phase 4 study that has completed, run by Texas Retina Associates. The registered enrollment target is 50 participants.
The verdict
NCT03984110, a Phase 4 study, has completed, sponsored by Texas Retina Associates.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
One Year Trial Evaluating Safety of Ozurdex With Eylea (COED)
Interventions
- DRUG Ozurdex
- DRUG Eylea
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-06-11 |
| Est. Completion | 2022-10-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03984110
The ClinicalTrials.gov registry entry for NCT03984110 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Retina Associates, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ozurdex is the first listed.
NCT03984110 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03984110 about?
NCT03984110 is a clinical study titled "One Year Trial Evaluating Safety of Ozurdex With Eylea". One Year Trial Evaluating Safety of Ozurdex With Eylea (COED)
What is the current status of trial NCT03984110?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2019-06-11. Estimated completion is 2022-10-27.
What interventions are being tested in trial NCT03984110?
The interventions under investigation include: Ozurdex (DRUG), Eylea (DRUG).
Who is sponsoring clinical trial NCT03984110?
This trial is sponsored by Texas Retina Associates, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.